Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: Results of the real world coroflex blue registry

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 1, 2010, Pages 78-85

  Bocksch, Wolfgang ^a   Pomar, Francisco ^b   Dziarmaga, Mieczyslaw ^c   Tresukosol, Damras ^d   Ismail, Omar ^e   Janek, Bronislav ^f   Carlsson, Joerg ^g   Simon, Jean Philippe ^h  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c Szpital Kliniczny Przemienienia Panskiego ^*  (Poland)

^d MAHIDOL UNIVERSITY   (Thailand)

^e HOSPITAL PULAU PINANG   (Malaysia)

^f INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^g Central Hospital of Kalmar   (Sweden)

^h Department of Cardiology   (France)

Author keywords

Angiography coronary; Cobalt chromium stent; Diagnostic cardiac catheterization; Percutaneous coronary intervention; Restenosis

Indexed keywords

CHROMIUM; COBALT; HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; RISK ASSESSMENT; STENT; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASIA; CHROMIUM ALLOYS; CORONARY STENOSIS; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 74249104884     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22208     Document Type: Article

References (36)

1. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group, Mancini GB. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008;359:677-687.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME;TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
4. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE; ENDEAVOR II Investigators. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798-806.
5. Serruys PW, Ong ATL, Piek JJ, Neumann FJ, Van Der Giesson WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm CW, Otto-Terlouw PC. A randomized comparison of a durable polymer everolimus eluting stent with a bare-metal coronary stent: The spirit first trial. EuroIntervention 2005;1:58-65.
6. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W; Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 2005;26:804-847.
7. Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, Bernheim A, Zutter A, Zellweger M, Grize L, Pfisterer ME; BASKET Investigators. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation baremetal stent in a real-world setting: Randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005;366:921-929.
8. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C; BASKET-LATE Investigator. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591.
9. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, Van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007;369:667-678.
10. Kastrati A, Dirschinger J, Boekstegers P, Elezi S, Schuehlen H, Pache J, Steinbeck G, Schmitt C, Ulm K, Neumann FJ, Schoemig A. Influence of stent design on 1-year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv 2000;50:290-297.
11. Pache J, Kastrati A, Mehilli J, Schühlen H, Dotzer F, Hausleiter J, Fleckenstein M, Neumann FJ, Sattelberger U, Schmitt C, Mueller M, Dirschinger J, Schoemig A. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003;41:1283-1288.
12. Briguori C, Sarais C, Pagnotta P, Liistro F, Montorfano M, Chieffo A, Sgura F, Corvaja N, Albiero R, Stankovic G, Toutoutzas C, Bonizzoni E, Di Mario C, Colombo A. In-stent restenosis in small coronary arteries: Impact of strut thickness. J Am Coll Cardiol 2002;40:403-409.
13. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, Mcfadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
14. Xu YW, Wei YD, Tang K, Chen YQ, Li WM, Yu XJ, Qin YW, Qi GX, Qu P, Hou YQ, Jain A, Grant P, Ramesh G, Ramesh B, Piamsomboon C, Kuanprasert S, Gwon HC, Cho YH, Kamar HH, Huang CX. Multi-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: A prospective, multi-center study. Chin Med J (Engl) 2007;120:1093-1096.
15. Sketch MH, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ. Driver Investigators. Evaluation of the Medtronic (Driver)cobalt-chromium alloy coronary stent system. Am J Cardiol 2005;95:8-12.
16. Kereiakes DJ, Choo JK, Young JJ, Broderick TM. Thrombosis and drug-eluting stents: A critical appraisal. Rev Cardiovasc Med 2004;5:9-15.
17. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;29:2126-2130.
18. Windecker S, Meier B. Late coronary stent thrombosis. Circulation 2007;116:1952-1965.
19. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.
20. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;33:496-501.
21. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP, Buller N, Bonser R, Van Den Brand MJ, Van Herwerden LA, Morel MA, Van Hout BA. Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.
22. Holmes DR, Savage M, Lablanche JM, Grip L, Serruys PW, Fitzgerald P, Fischman D, Goldberg S, Brinker JA, Zeiher AM, Shapiro LM, Willerson J, Davis BR, Ferguson JJ, Popma J, King SB, Lincoff AM, Tcheng JE, Chan R, Granett JR, Poland M. Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 2002;106:1243-1250.
23. Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, Deme M, Stoll HP. e-Cypher Investigators. Safety of coronary sirolimus-eluting stents in daily clinical practice: One-year follow-up of the e-Cypher registry. Circulation 2006;113:1434-1434.
24. Lasala JM, Cox DA, Dobies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS. ARRIVE 1 Participating Physicians. Usage patterns and 2-year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry. Catheter Cardiovasc Interv 2008;72:433-445.
25. Zahn R, Hamm CW, Schneider S, Zeymer U, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Senges J; German Cypher Stent Registry. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am J Cardiol 2005;95:1302-1308.
26. Kastrati A, Mehilli J, Von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A; ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005;293:165-171.
27. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: The INHIBIT randomised controlled trial. Lancet 2002;359:551-557.
28. Stone GW, Ellis SG, O'shaughnessy CD, Martin SL, Satler L, Mcgarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME. TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within baremetal stents: The TAXUS V ISR randomized trial. JAMA 2006;295:1253-1263.
29. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-2124.
30. Park SJ, Park SW, Hong MK, Lee CW, Lee JH, Kim JJ, Jang YS, Shin EK, Yoshida Y, Tamura T, Kimura T, Nobuyoshi M. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol 2003;91:12-16.
31. Werner GS, Krack A, Schwarz G, Prochnau D, Betge S, Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 2004;44:2301-2306.
32. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000;35:929-936.
33. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: Comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-356.
34. Colombo A, Bramucci E, Saccà S, Violini R, Lettieri C, Zanini R, Sheiban I, Paloscia L, Grube E, Schofer J, Bolognese L, Orlandi M, Niccoli G, Latib A, Airoldi F. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. Circulation 2009;119:71-78.
35. Cutlip DE, Chauhan MS, Baim DS, Ho KK, Popma JJ, Carrozza JP, Cohen DJ, Kuntz RE. Clinical restenosis after coronary stenting: Perspectives from multicenter clinical trials. J Am Coll Cardiol 2002;40:2082-2089.
36. Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N, Sangiorgi G, Ferraro M, Briguori C, Montorfano M, Carlino M, Colombo A. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: Immediate and mid-term results. J Am Coll Cardiol 2004;43:1154-1160.